"Health care leader whose mission is to keep you healthy. Under-one-roof convenience, 24-hour advice nurse, and online access to manage your health anytime."

During the past decade, Kaiser Permanente Northwest Oncology Hematology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Northwest Oncology Hematology" #1 collaborator was "Celgene Corporation" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Northwest Oncology Hematology" are "B-cell Chronic Lymphocytic Leukemia" (1 trials), "Leukemia, Myeloid, Acute" (1 trials), "Multiple Myeloma" (1 trials), "Myelodysplastic Syndrome" (1 trials) and "Ovarian Neoplasms" (1 trials). Many other conditions were trialed in "Kaiser Permanente Northwest Oncology Hematology" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Northwest Oncology Hematology" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Oral Azacitidine" (2 trials), "Abraxane®" (1 trials), "Atezolizumab" (1 trials) and "Best Supportiv Care (BSC)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Northwest Oncology Hematology" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kaiser Permanente Northwest Oncology Hematology". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Kaiser Permanente Northwest Oncology Hematology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Northwest Oncology Hematology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".